Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Q2 2024 Earnings Call Transcript
Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Q2 2024 Earnings Call Transcript August 9, 2024Amneal Pharmaceuticals, Inc. misses on earnings expectations.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | Rubric Capital Management David Rosen | 10,721,778 | $68,083,290 | +13% | 1.78% |
2. | Citadel Investment Group Ken Griffin | 9,988,725 | $63,428,404 | +98% | 0.01% |
3. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 2,669,943 | $16,954,138 | +2% | 0.99% |
4. | Blackbarn Capital Jonathan Carter | 2,000,000 | $12,700,000 | +42% | 1.12% |
5. | Woodline Partners Michael Rockefeller And Karl Kroeker | 1,315,023 | $8,350,396 | +92% | 0.07% |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$4.21 | 50,000 | Director | 258,784 | 2021-12-17 | Filing | |
$4.25 | 50,000 | Large Shareholder, Officer, Director | 512,566 | 2021-12-16 | Filing | |
$4.13 | 100,000 | Large Shareholder, Officer, Director | 462,566 | 2021-12-15 | Filing | |
$4.25 | 50,000 | Officer, Director | 512,566 | 2021-12-16 | Filing | |
$4.13 | 100,000 | Officer, Director | 462,566 | 2021-12-15 | Filing |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$7.85 | 40,225 | Officer | 256,670 | 2024-08-15 | Filing | |
$7.81 | 22,486 | Officer | 296,895 | 2024-08-14 | Filing | |
$7.75 | 100,000 | Officer | 291,666 | 2024-08-14 | Filing | |
$6.73 | 23,447 | Director | 93,402 | 2024-05-17 | Filing | |
$6.76 | 14,553 | Director | 116,849 | 2024-05-16 | Filing |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 21,521,301 | $130,634,297 | 26.61% | |
2. | 13,642,387 | $82,809,287 | 0% | |
3. | 12,328,767 | $74,835,616 | 1.2% | |
4. | 8,846,421 | $53,697,775 | 0% | |
5. | 3,741,007 | $22,717,998 | 0.01% |